Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options? Caserta S, Martino EA, Vigna E, Bruzzese A, et al. Eur J Haematol 2025 Sep 13. doi: 10.1111/ejh.70036.

Read + Share

Amedeo Smart

Independent Medical Education

Caserta S, Martino EA, Vigna E, Bruzzese A, et al. Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options? Eur J Haematol 2025 Sep 13. doi: 10.1111/ejh.70036.
PMID: 40944468